Herpes Zoster Clinical Trials

31 recruitingLast updated: May 13, 2026

There are 31 actively recruiting herpes zoster clinical trials across 15 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 4, Phase 3. Top locations include Beijing, China, Zunyi, Guizhou, China, Wuhan, Hubei, China. Updated daily from ClinicalTrials.gov.


Herpes Zoster Trials at a Glance

31 actively recruiting trials for herpes zoster are listed on ClinicalTrialsFinder across 6 cities in 15 countries. The largest study group is Not Applicable with 12 trials, with the heaviest enrollment activity in Beijing, Zunyi, and Wuhan. Lead sponsors running herpes zoster studies include Beijing Tiantan Hospital, GlaxoSmithKline, and CHA Vaccine Institute Co., Ltd..

Browse herpes zoster trials by phase

Treatments under study

About Herpes Zoster Clinical Trials

Looking for clinical trials for Herpes Zoster? There are currently 22 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Herpes Zoster trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Herpes Zoster clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 31 trials

Recruiting
Phase 1Phase 2

Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population

Herpes Zoster
National Institute of Allergy and Infectious Diseases (NIAID)225 enrolled1 locationNCT05580458
Recruiting
Phase 4

A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland

Herpes Zoster
GlaxoSmithKline33,609 enrolled8 locationsNCT07502560
Recruiting
Phase 3

Shingrix in Renal Transplant Recipients

Kidney FailureKidney TransplantationKidney Failure, Chronic+2 more
University of Colorado, Denver132 enrolled4 locationsNCT04128189
Recruiting
Not Applicable

Efficacy of Electroacupuncture for Acute Herpes Zoster-Associated Pain and Biomarker Evaluation

Acute Herpes Zoster
Dexiong Han228 enrolled1 locationNCT07515885
Recruiting
Not Applicable

The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster

Postherpetic NeuralgiaPainHerpes Zoster
Beijing Tiantan Hospital832 enrolled1 locationNCT07361796
Recruiting
Not Applicable

The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster

PainHerpes ZosterMirogabalin
Beijing Tiantan Hospital750 enrolled1 locationNCT07307170
Recruiting
Phase 1Phase 2

A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant

Herpes Zoster
GlaxoSmithKline184 enrolled31 locationsNCT04006808
Recruiting

Erector Spinae Plane Block Versus Transcutaneous Radiofrequency in Postherpetic Neuralgia

Postherpetic NeuralgiaHerpes ZosterNeuropathic Pain
Diskapi Teaching and Research Hospital50 enrolled1 locationNCT07400640
Recruiting
Phase 1Phase 2

Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine

Herpes ZostermRNA Vaccine
Sinovac Biotech Co., Ltd519 enrolled1 locationNCT07400003
Recruiting
Not Applicable

Electroacupuncture Regulation of Immune Cells in Herpes Zoster

ElectroacupunctureHerpes ZosterImmune
First People's Hospital of Hangzhou8 enrolled1 locationNCT06643247
Recruiting
Not Applicable

The Analgesic Efficacy and Safety of Flurbiprofen Patch in Patients With Herpes Zoster

PainHerpes Zoster
Beijing Tiantan Hospital750 enrolled1 locationNCT07370402
Recruiting
Not Applicable

The Analgesic Efficacy and Safety of Loxoprofen Sodium Patch in Patients With Herpes Zoster

PainHerpes Zoster
Beijing Tiantan Hospital750 enrolled1 locationNCT07378059
Recruiting
Not Applicable

The Analgesic Efficacy and Safety of Baclofen in Patients With Herpes Zoster

PainHerpes Zoster
Beijing Tiantan Hospital750 enrolled1 locationNCT07378046
Recruiting
Not Applicable

The Analgesic Efficacy and Safety of Tulodesvenlafaxine in Patients With Herpes Zoster

PainHerpes Zoster
Beijing Tiantan Hospital750 enrolled1 locationNCT07370389
Recruiting
Not Applicable

The Analgesic Efficacy and Safety of Desvenlafaxine in Patients With Herpes Zoster

PainHerpes Zoster
Beijing Tiantan Hospital750 enrolled1 locationNCT07361809
Recruiting
Not Applicable

The Analgesic Efficacy and Safety of Crisugabalin in Patients With Herpes Zoster

PainHerpes Zoster
Beijing Tiantan Hospital750 enrolled1 locationNCT07307976
Recruiting
Phase 1Phase 2

A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals

Herpes Zoster (HZ)
Shanghai Institute Of Biological Products645 enrolled1 locationNCT06932523
Recruiting
Phase 4

Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster

Herpes Zoster
Peking University Third Hospital140 enrolled4 locationsNCT07099157
Recruiting

A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.

Vascular DementiaHerpes Zoster (HZ)
Center for Clinical Studies, Texas375 enrolled2 locationsNCT06903078
Recruiting
Phase 1Phase 2

Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over

vaccine preventable diseasesHerpes ZosterShingles
Dynavax Technologies Corporation764 enrolled13 locationsNCT06569823